Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.8k Views
No more insights
ENTITY
SMARTSCORE: 2.8/5
Chiome Bioscience (4583 JP)
Chiome Bioscience (4583 JP)
1
Analysis
Health Care • Japan
Chiome Bioscience Inc. designs, develops, and sells monoclonal antibody products for medicine, diagnosis, testing, and life sciences researches. The Company offers research tools and examination material, including diagnostic kits and ethical drugs.
morex